Earnings History Data for Plus Therapeutics (PSTV) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Plus Therapeutics

Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
02-06-2025	PM		PSTV	Plus Therapeutics	5.00	-0.56	-0.17	0.00	Plus Therapeutics GAAP EPS of -$1.19 misses by $0.97, revenue of $1.06M misses by $0.08M [6/2/2025 12:31 AM]	0.3660	0.08 (27.57%)	0.40	0.11 (39.49%)	0.24 - 2.67	117,123,273	5,770,000	43,363,685
Plus Therapeutics GAAP EPS of -$1.19 misses by $0.97, revenue of $1.06M misses by $0.08M [6/2/2025 12:31 AM] Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights [2025-05-30 04:15PM] The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates [May-29-25 05:30PM] Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates [2025-05-30 05:25PM] Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates [2025-05-30 05:20PM]
27-03-2025	AH		PSTV	PLUS THERAPEUTICS, Inc.	8.43	-0.67	-0.50	-0.70	Plus Therapeutics GAAP EPS of -$2.34 misses by $0.59, revenue of $5.82M beats by $0.29M [3/27/2025 4:23 PM]	1.17	-0.35 (-23.19%)	1.35	-0.17 (-11.18%)	0.24 - 2.67	2,780,121	45,910,000	301,438
Plus Therapeutics GAAP EPS of -$2.34 misses by $0.59, revenue of $5.82M beats by $0.29M [3/27/2025 4:23 PM] Plus Therapeutics outlines REYOBIQ expansion plans and CNSide launch timeline [3/27/2025 7:42 PM] Plus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights [2025-03-27 04:05PM] Q4 2024 Plus Therapeutics Inc Earnings Call [2025-03-28 01:12PM] Plus Therapeutics Inc (PSTV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... [2025-03-28 03:04AM] Plus Therapeutics, Inc. (PSTV) Q4 2024 Earnings Call Transcript [Mar-27-25 07:42PM] Plus Therapeutics (PSTV) Reports Q4 Loss, Misses Revenue Estimates [Mar-27-25 05:35PM]
14-11-2024	AH		PSTV	PLUS THERAPEUTICS, Inc.	7.61	-0.46	-0.46	1.00	Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M [11/14/2024 4:25 PM]	1.16	-0.10 (-7.94%)	1.29	0.03 (2.38%)	1.14 - 2.78	128,881	190,000	200
Plus Therapeutics GAAP EPS of -$0.37 beats by $0.19, revenue of $1.45M beats by $0.31M [11/14/2024 4:25 PM] Plus Therapeutics Inc (PSTV) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ... [2024-11-15 02:16AM] Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Nov-14-24 04:15PM]
14-08-2024	AH		PSTV	PLUS THERAPEUTICS, Inc.	8.27	-0.71	0.00	-0.59	Plus Therapeutics GAAP EPS of -$0.71 misses by $0.18, revenue of $1.27M beats by $0.15M [8/14/2024 4:50 PM]	1.40	-0.02 (-1.41%)	1.45	0.03 (2.11%)	0.97 - 3.21	28,781	70,000	600
Plus Therapeutics GAAP EPS of -$0.71 misses by $0.18, revenue of $1.27M beats by $0.15M [8/14/2024 4:50 PM]
15-05-2024	AH		PSTV	PLUS THERAPEUTICS, Inc.	9.24	-0.75	-0.25	-31.47	Plus Therapeutics GAAP EPS of -$0.75 beats by $0.34, revenue of $1.67M misses by $0.02M [5/15/2024 4:22 PM]	2.18	-0.14 (-6.03%)	2.32	0.0 (0.00%)	0.97 - 4.45	37,234	290,000	1,187
Plus Therapeutics GAAP EPS of -$0.75 beats by $0.34, revenue of $1.67M misses by $0.02M [5/15/2024 4:22 PM]
05-03-2024	AH		PSTV	Plus Therapeutics	9.00	-0.70	-0.78	0.00	Plus Therapeutics GAAP EPS of -$4.24 misses by $3.07 [3/5/2024 4:09 PM]	1.93	-0.25 (-11.47%)	2.30	0.12 (5.50%)	0.97 - 5.24	70,567	30,000	7,888
Plus Therapeutics GAAP EPS of -$4.24 misses by $3.07 [3/5/2024 4:09 PM]
31-10-2023	AH		PSTV	PLUS THERAPEUTICS, Inc.	3.11	-1.00	-0.58	-42.71	Plus Therapeutics GAAP EPS of -$1.00 beats by $0.18, revenue of $1.24M beats by $0.08M [10/31/2023 4:11 PM]	1.27	0.05 (4.11%)	1.36	0.14 (11.48%)	0.97 - 7.50	710,391	210,000	500,378
Plus Therapeutics GAAP EPS of -$1.00 beats by $0.18, revenue of $1.24M beats by $0.08M [10/31/2023 4:11 PM] Plus Therapeutics stock jumps on $500,000 share repurchase program [10/31/2023 4:17 PM]
14-08-2023	AH		PSTV	PLUS THERAPEUTICS, Inc.	7.88	-0.59	-1.91	-53.95	Plus Therapeutics GAAP EPS of -$0.59 beats by $1.44 [8/14/2023 4:07 PM]	2.44	-0.06 (-2.60%)	2.31	-0.19 (-7.60%)	1.97 - 18.00	52,225	100,000	1,454
Plus Therapeutics GAAP EPS of -$0.59 beats by $1.44 [8/14/2023 4:07 PM]
20-04-2023	AH	4:05 PM ET (Apr 20)	PSTV	PLUS THERAPEUTICS, Inc.	9.95	-0.14	-0.14	-0.19	Plus Therapeutics GAAP EPS of -$0.14 beats by $0.01 [4/20/2023 4:07 PM]	0.2605	-0.05 (-15.12%)	0.29	-0.02 (-6.39%)	0.25 - 1.20	1,040,031	370,000	24,243
Plus Therapeutics GAAP EPS of -$0.14 beats by $0.01 [4/20/2023 4:07 PM]
23-02-2023	AH	4:05 PM ET (Feb 23)	PSTV	PLUS THERAPEUTICS, Inc.	12.15	-0.16	-0.15	-0.27	Plus Therapeutics GAAP EPS of -$0.77 misses by $0.02, revenue of $0.22M misses by $0.5M [2/23/2023 4:18 PM]	0.3724	-0.02 (-5.00%)	0.37	-0.02 (-5.36%)	0.29 - 1.20	187,263	250,000	15,760
Plus Therapeutics GAAP EPS of -$0.77 misses by $0.02, revenue of $0.22M misses by $0.5M [2/23/2023 4:18 PM]
20-10-2022	AH	4:05 PM ET (Oct 20)	PSTV	PLUS THERAPEUTICS, Inc.	11.32	-0.19	-0.21	-0.28	Plus Therapeutics GAAP EPS of -$0.19 beats by $0.02, revenue of $73K [10/20/2022 4:15 PM]	0.4652	-0.01 (-3.08%)	0.48	0.0 (0.00%)	0.39 - 2.16	264,464	2,640,000	4,067
Plus Therapeutics GAAP EPS of -$0.19 beats by $0.02, revenue of $73K [10/20/2022 4:15 PM] Plus Therapeutics Q3 net loss widens Y/Y [10/21/2022 10:36 AM] Plus Therapeutics Presents Preliminary Safety and Feasibility Data from ReSPECT-LM Clinical Trial at the European Association of Nuclear Medicine Congress [Oct-19-22 07:00AM] Plus Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights [Oct-20-22 04:05PM]
21-07-2022	AH	4:05 PM ET (Jul 21)	PSTV	PLUS THERAPEUTICS, Inc.	10.66	-0.24	-0.18	-0.25	Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02 [7/21/2022 4:11 PM]	0.5351	0.03 (4.92%)	0.54	0.03 (5.88%)	0.39 - 2.60	126,246	70,000	14,715
Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02 [7/21/2022 4:11 PM] Plus Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights [Jul-21-22 04:05PM]
21-04-2022	AH	4:05 PM ET (Apr 21)	PSTV	PLUS THERAPEUTICS, Inc.	19.29	-0.19	-0.17	-0.33	Plus Therapeutics GAAP EPS of -$0.19 misses by $0.01 [4/21/2022 4:27 PM]	0.7426	-0.14 (-15.80%)	0.88	0.0 (-0.23%)	0.72 - 3.54	579,345	300,000	2,425
Plus Therapeutics GAAP EPS of -$0.19 misses by $0.01 [4/21/2022 4:27 PM] Plus Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights [Apr-21-22 04:05PM]
24-02-2022	AH	4:05 PM ET (Feb 24)	PSTV	PLUS THERAPEUTICS, Inc.	21.39	-0.27	-0.23	-0.73	Plus Therapeutics GAAP EPS of -$1.11 misses by $0.01 [2/24/2022 4:55 PM]	1.01	0.01 (0.50%)	1.03	0.02 (1.98%)	0.81 - 3.54	24,192	260,000	4,007
Plus Therapeutics GAAP EPS of -$1.11 misses by $0.01 [2/24/2022 4:55 PM] Plus Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights [Feb-24-22 04:05PM]
21-10-2021	AH	4:05 PM ET (Oct 21)	PSTV	PLUS THERAPEUTICS, Inc.	26.18	-0.28	-0.21	-0.39	Plus Therapeutics EPS misses by $0.04 [10/21/2021 4:28 PM]	1.66	-0.07 (-4.05%)	1.70	-0.03 (-1.73%)	1.59 - 5.42	334,488	210,000	12,805
Plus Therapeutics EPS misses by $0.04 [10/21/2021 4:28 PM] Plus Therapeutics shares fall after Q3 results, cash position update [10/22/2021 10:08 AM] Plus Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights [Oct-21-21 04:05PM]
22-07-2021	AH	4:05 PM ET (Jul 22)	PSTV	PLUS THERAPEUTICS, Inc.	22.93	-0.25	-0.23	-0.45	Plus Therapeutics EPS misses by $0.01 [7/22/2021 4:08 PM]	2.17	-0.11 (-4.82%)	2.21	-0.07 (-3.07%)	1.92 - 5.42	206,475	380,000	10,486
Plus Therapeutics jumps 11% on treatment of first patient in latest cohort of ReSPECT-GBM trial [7/22/2021 8:50 AM] Plus Therapeutics EPS misses by $0.01 [7/22/2021 4:08 PM] Plus Successfully Treats First Patient in Latest Dosing Cohort in ReSPECT-GBM Trial [Jul-22-21 07:00AM] Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights [Jul-22-21 04:05PM]
22-04-2021	AH	4:05 PM ET (Apr 22)	PSTV	PLUS THERAPEUTICS, Inc.	18.90	-0.33	-0.31	-0.28	Plus Therapeutics EPS beats by $0.03 [4/22/2021 4:15 PM]	2.38	0.15 (6.47%)	2.45	0.21 (9.38%)	1.40 - 5.42	373,863	400,000	34,793
Plus Therapeutics EPS beats by $0.03 [4/22/2021 4:15 PM] Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights [Apr-22-21 04:05PM]
22-02-2021	AH	4:05 PM ET (Feb 22)	PSTV	PLUS THERAPEUTICS, Inc.	16.20	-0.73	-0.33	0.12	Plus Therapeutics EPS misses by $1.46 [2/22/2021 4:13 PM]	3.12	-0.63 (-16.81%)	3.32	-0.43 (-11.47%)	0.93 - 5.42	1,122,321	2,913,124	76,974
Plus Therapeutics EPS misses by $1.46 [2/22/2021 4:13 PM] Plus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights [Feb-22-21 04:05PM] Plus Therapeutics, Inc. to Host Earnings Call [Feb-22-21 02:45PM]
22-10-2020	AH	After the close (Oct 22)	PSTV	PLUS THERAPEUTICS, Inc.	12.17	-0.39	0.00	-0.03	Plus Therapeutics EPS beats by $0.16 [10/22/2020 4:11 PM]	2.58	-0.18 (-6.52%)	2.68	-0.08 (-2.90%)	0.93 - 3.56	121,279	122,805	1,576